Medications are the mainstay of treatment for multiple sclerosis (MS). Many of them are used to block the immune system's attack on the nerves and slow or prevent progression and relapses (flare-ups) ...

Multiple sclerosis (MS) is one of the most widespread disabling neurological conditions of young adults around the world. It affects almost 1 million people in the United States, and about 2.9 ...

Multiple sclerosis diagnosed in people under 18 is called pediatric MS or pediatric-onset multiple sclerosis (POMS). It’s associated with more frequent relapses but a slower accumulation of ...

MS University Result 2025: Manonmaniam Sundaranar University is located in Tamil Nadu's Tirunelveli. MS University Result 2025: Manonmaniam Sundaranar University (MSU) has announced the results of ...

Icon Energy Corp. ATHENS, Greece, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Icon Energy Corp. (“Icon” or the “Company”) (Nasdaq: ICON), an international shipping company that provides worldwide ...

A new website aims to provide support to caregivers of people with multiple sclerosis (MS). The site, MS Care Partner Connection, brings together information on how caregivers can care for ...

The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) has cleared Pheno Therapeutics to initiate a first-in-human Phase 1 clinical trial to test its oral candidate PTD802 in ...